These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37900127)

  • 1. Research progress on moyamoya disease combined with thyroid diseases.
    Zhang G; Liu E; Tan X; Liu C; Yang S
    Front Endocrinol (Lausanne); 2023; 14():1233567. PubMed ID: 37900127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of Moyamoya disease in a girl with thyrotoxicosis.
    Lee R; Sung K; Park YM; Yu JJ; Koh YC; Chung S
    Yonsei Med J; 2009 Aug; 50(4):594-8. PubMed ID: 19718414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.
    Kim JE; Jeon JS
    Neurol Res; 2014 May; 36(5):407-16. PubMed ID: 24641716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nationwide survey on unilateral moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease.
    Kim JY; Kim BS; Kang JH
    Int J Cardiol; 2001 Aug; 80(1):101-3. PubMed ID: 11575263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.
    Im SH; Oh CW; Kwon OK; Kim JE; Han DH
    J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Embryonic Development of Cerebral Arteries as a Potential Cause of Moyamoya Disease.
    Tan C; Niu H; Duan R; Shi G; Zhao Y; Chen X; Ye X; Wang R
    World Neurosurg; 2019 Sep; 129():e224-e232. PubMed ID: 31125778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review.
    Rallo MS; Akel O; Gurram A; Sun H
    Neurosurg Focus; 2021 Sep; 51(3):E5. PubMed ID: 34469865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress on Complications of Direct Bypass for Moyamoya Disease.
    Yu J; Shi L; Guo Y; Xu B; Xu K
    Int J Med Sci; 2016; 13(8):578-87. PubMed ID: 27499690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress of moyamoya disease combined with renovascular hypertension.
    Liu E; Zhao H; Liu C; Tan X; Luo C; Yang S
    Front Surg; 2022; 9():969090. PubMed ID: 36090342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
    Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexisting diseases of moyamoya vasculopathy.
    Wei YC; Liu CH; Chang TY; Chin SC; Chang CH; Huang KL; Chang YJ; Peng TI; Lee TH
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1344-50. PubMed ID: 24468071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological features of middle cerebral arteries from patients treated for Moyamoya disease.
    Takagi Y; Kikuta K; Nozaki K; Hashimoto N
    Neurol Med Chir (Tokyo); 2007 Jan; 47(1):1-4. PubMed ID: 17245006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Suyama K; Nagata I
    Clin Neurol Neurosurg; 2013 Jul; 115(7):930-3. PubMed ID: 23041378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya disease: a summary.
    Burke GM; Burke AM; Sherma AK; Hurley MC; Batjer HH; Bendok BR
    Neurosurg Focus; 2009 Apr; 26(4):E11. PubMed ID: 19335127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
    Ohba S; Nakagawa T; Murakami H
    Neurosurg Rev; 2011 Jul; 34(3):297-304; discussion 304. PubMed ID: 21424208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult moyamoya disease in the asymptomatic Japanese population.
    Ikeda K; Iwasaki Y; Kashihara H; Hosozawa K; Anan K; Tamura M; Satoyoshi E; Ikeda H
    J Clin Neurosci; 2006 Apr; 13(3):334-8. PubMed ID: 16540331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.